Medical Product Regulatory Affairs. Pharmaceuticals, Diagnostics, Medical Devices

  • ID: 2183161
  • Book
  • 297 Pages
  • John Wiley and Sons Ltd
1 of 4
Written in a clear and concise style by an experienced author, this attractively–priced book covers regulatory affairs in all major global markets for pharmaceuticals and medical devices, making it the most comprehensive in its field.

Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics dealt with include CDER, CBER and marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/Manufacturing Practices.

Everything pharmacologists, bioengineers, pharma engineers, students in pharmacy and those working in the pharmaceutical industry need to know about medical regulatory affairs.
Note: Product cover images may vary from those shown
2 of 4
What is a drug, and what is a device? Basic principles and definitions of healthcare products

The regulatory framework: FDA, EMEA, other regulatory authorities

The drug development process: pre–clinical and clinical studies

Medical devices: design control, validation, risk management

Regulatory submissions: forms and requirements

Quality systems: GMP, ISO norms, software validation

Post–marketing issues: surveillance, corrective and preventive actions

World harmonization of regulatory requirements
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
"This book is an excellent reference for people starting out in regulatory affairs, as well as those working within the area whose product portfolio is adapting and changing." (Microbiology Today, May 2009)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll